Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • MedTech, HealthTech, Benzinga, BioSig Technologies, BioPharmaceuticals, Jessica Abraham, Jessica N Abraham,
    Business,  Benzinga,  Biotechnology,  Health,  Technology

    MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    April 7, 2022 /

    This article was previously published to Benzinga. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the heart’s rhythm, leading it to beat out of sync with the rest of the body.  Not every patient experiences arrhythmia in the same way, so it’s sometimes necessary for doctors to provide each patient with a personalized approach to treatment and recovery.  Lifestyle choices and comorbidities, medication, stress and environmental factors can cause the heart to beat out of sync. The world is experiencing an uptick in arrhythmia cases linked to the after effects of COVID-19. Atrial fibrillation (AFib) is the…

    read more
    Jessica N. Abraham Comments Off on MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    You May Also Like

    Android,China Wholesale Company,Intel,Kodi,M1 Mini ,PC,MeeGoPad T02,Mini Computer,PC,Technology,Technology News, Windows 10,World's Smallest Android

    Chinavision Releases World’s Smallest Dual Full-Function PC & Android Device

    September 9, 2015
    AR,Augmented Reality,Construction,Google Glass,Google Goggles,Logistics,MA Labs,Maintenance Assistant,Operations Management,Project Management,Shipping,supply chain,Technology,Technology News,Virtual Reality,VR,WarehouseXR,ag

    MA Labs Announces Maintenance Assistant

    September 15, 2016
    Cloud Computing Magazine, AWS, Cloud, Cloud Computing, Explained, Key Terms, PaaS, SaaS, Data Science, Deep Learning, Machine Learning,IaaS, Cloud Portability, Remote Access, Security, Vertical Cloud, Consumer Cloud, Server, Network, Hybrid Systems, Multi-Tenancy, Xaas, Anything-as-a-Service, DaaS, PaaS, Software-as-a-Service, Software Applications, Work Solutions, Business Solutions, Enterprise Solutions, Remote Workforce, Productivity, Workforce Optimization, Platform-as-a-Service, Infrastructure-as-a-Service,Flexibility,Private Networks, Virtual Private Networks, VPN, Virtualization,

    Too Legit to Quit: Why Skullcandy is Teaming Up with Icertis

    February 23, 2016
  • Statera Pharmaceuticals treatment for Covid-19 Long-Haulers
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) recently announced that it has officially received Institutional Review Board (IRB) approval to conduct a Phase 1 pilot study at Loma Linda University Health to evaluate STAT-205 as a treatment in the mitigation of SARS-CoV-2 progression. STAT-205 is a breakthrough immuno-modulator designed to decrease elevated inflammatory responses that are associated with viral infections and inhibit viral replication in human lung cells. Its efficacy was successfully demonstrated during preclinical in vitro studies, where STAT-205 was able to inhibit the replication of…

    read more
    Jessica N. Abraham Comments Off on Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    You May Also Like

    Green Policy, Generation Hemp, Melissa Pagen, Gary C Evans, Industrial Hemp Processor, Hemp Cleaning, Green Policy, ESG

    Generation Hemp’s Green Policy is Inspired by a Cause, Executives Move From Oil and Gas to Industrial Green

    August 30, 2021
    Generation Hemp, Industrial Hemp, Pet Bedding, Animal Bedding, Not Hay, Not Straw, Mold-Free, Pest-Free, Sustainable

    Rowdy Rooster Hemp Unleashed | Official Launch of Generation Hemp’s Animal Bedding Brand for Small Animals

    September 29, 2021
    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021
  • What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
    Business,  Benzinga,  Biotechnology,  Finance,  Health

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…

    read more
    Jessica N. Abraham Comments Off on What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    You May Also Like

    Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021
    Healthcare Apps, Unified Communications, WebRTC, IoT, RFID, Healthcare Solutions, RTC, Web RTC, Real Time Communications, Unified Communications, Remote Collaboration, Enterprise Collaboration, Enterprise Solutions, Business Solutions, Contact Center, Remote Workforce, TMC Net, TMCNet, Technology News, Tech News, Technology Marketing News,

    Virtual Reality from Google: Headed to a K-12 Near You

    November 23, 2015
    .me, Branding, Social Branding, Persona, Brand Persona, GoDaddy, Contest, ICANN, Interactive Experiences, Internet Marketing, Digital Marketing, Loyalty Programs, Net Neutrality, Personalization, Power of the Hashtag, Social Media, Content Development, Social Society, The Power of Blogging, Resume, Blogging, The Vault, Examiner,

    .me creators rewarded for “making the Internet personal”

    January 5, 2014
  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    industrial Hemp, Generation Hemp, GENH, Hemp, Cannabis, Textiles, Manufacturing,

    Why Is There a Renewed Interest in Hemp by Textile and Manufacturing Companies?

    August 6, 2021
    Generation Hemp, Industrial Hemp, Pet Bedding, Animal Bedding, Not Hay, Not Straw, Mold-Free, Pest-Free, Sustainable

    Rowdy Rooster Hemp Unleashed | Official Launch of Generation Hemp’s Animal Bedding Brand for Small Animals

    September 29, 2021
    Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021
  • Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics
    Business,  Benzinga,  Finance,  Health,  Regenerative Medicine

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Age-related macular degeneration (AMD) is a disease originating in the retina, which may worsen over time, according to WebMD. It’s said to be the leading cause of severe, permanent vision loss in people older than 60.  When the macula — the small central portion of the retina — wears down, the light-sensing nerve tissue at the back of the eye begins to deteriorate. While it doesn’t always cause complete blindness, severe vision problems such as loss of central vision may occur. As the condition worsens,…

    read more
    Jessica N. Abraham Comments Off on Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    You May Also Like

    Digital Gadgetry,Digital Pivot,HeLi-on,Portable,Solar Mobile Charger,Solar Technology,Sun Power,Technology,Technology News,

    HeLi-on, The Goddess to Mobile Solar Technology

    November 13, 2015
    DISC Insights, DISC Personality, Personality Type, Corporate Culture, Employee Relations, Persona, Behavioral Analysis, Coaching, Dominance, Influence, Hiring Cycles, Recruitment, Talent Acquisition, Onboarding, Team Building, Leadership, Workforce Optimization, Corporate Development, Business Development, Business Expansion, Growth, Team Building, Culture, Building Remote Teams, Compliances, Roles, Infrastructure, Differences in Opinion, Compliance, Steadiness

    6 ways to build your coaching network offline

    July 30, 2019
    DISC Insights, DISC Personality, Personality Type, Corporate Culture, Employee Relations, Persona, Behavioral Analysis, Coaching, Dominance, Influence, Hiring Cycles, Recruitment, Talent Acquisition, Onboarding, Team Building, Leadership, Workforce Optimization, Corporate Development, Business Development, Business Expansion, Growth, Team Building, Culture, Building Remote Teams, Compliances, Roles, Infrastructure, Differences in Opinion,

    Turn your consulting energy into coaching revenue

    January 14, 2020
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.